论文部分内容阅读
目的:探讨布地奈德联合特布他林雾化吸入治疗小儿支气管肺炎的临床治疗方法和治疗效果。方法:选取2012年6月~2013年6月来我院接受治疗的100例支气管肺炎患儿,随机将其分为观察组和对照组各50例,我院给予对照组患儿采用常规基础治疗,给予观察组患儿在对照组常规基础治疗基础上采用布地奈德联合特布他林雾化吸入治疗,比较两组患儿的治疗效果以及临床体征消失情况和住院情况等。结果:观察组患儿总有效率高达96%,而对照组患儿总有效率为78%,观察组明显好于对照组,P<0.05表示比较差异具有统计学意义。观察组患儿在咳嗽、气促、湿性啰音、双肺哮鸣音等临床症状的改善以及住院时间的比较上都明显要好于对照组患儿,P<0.05表示比较差异存在统计学意义。结论:采用布地奈德联合特布他林雾化吸入治疗小儿支气管肺炎取得了很好的临床治疗效果,安全可靠,值得在临床上广泛推广和应用。
Objective: To investigate the clinical treatment and therapeutic effect of budesonide combined with terbutaline in the treatment of infantile bronchial pneumonia. Methods: A total of 100 cases of bronchial pneumonia treated in our hospital from June 2012 to June 2013 were randomly divided into observation group (50 cases) and control group (50 cases). The control group received routine basic treatment The observation group was treated with budesonide combined with terbutaline in the control group on the basis of conventional basic therapy. The therapeutic effect, disappearance of clinical signs and hospitalization were compared between the two groups. Results: The total effective rate in the observation group was as high as 96%, while the total effective rate in the control group was 78%. The observation group was significantly better than the control group. P <0.05 indicated that the difference was statistically significant. The observation group children in cough, shortness of breath, wet rales, lung lung wheeze and other clinical symptoms and hospital stay were significantly better than the control group children, P <0.05 said the difference was statistically significant. Conclusion: The use of budesonide combined with terbutaline hydrochloride nebulization in children with bronchial pneumonia has achieved good clinical effect, safe and reliable, it is worth widely used in clinical practice.